Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29225342 | 1.00 | CHRM2 (0.50) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL817873 | 0.97 | CHRM2 (0.55) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL16492062 | 0.97 | CHRM2 (0.48) | CHRM2NFKB1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL19555655 | 0.97 | CHRM2 (0.48) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL560600 | 0.97 | CHRM2 (0.55) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL63987 | 0.96 | NFKB1 (0.54) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL636385 | 0.96 | CHRM2 (0.45) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL10972803 | 0.94 | LCK (0.48) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL2402964 | 0.93 | CHRM2 (0.50) | CHRM2NFKB1CA12CA1CA2 | |
| SCHEMBL720253 | 0.93 | CHRM2 (0.58) | CHRM2NFKB1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025047826-A1 | CHROMATOGRAPHY CARRIER AND METHOD FOR PURIFYING ANTIBODY | JNC株式会社 | 2025-03-06 | — | — | WO | claimed |
| EP-3894477-B1 | CONTROLLED CURE FOR COMPOSITIONS COMPRISING ACETOACETYLATED RESINS | EASTMAN CHEM CO (US) | 2025-01-15 | — | — | EP | claimed |
| EP-3894475-B1 | ASSEMBLY COMPONENTS COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS | EASTMAN CHEM CO (US) | 2024-06-19 | — | — | EP | claimed |
| US-11820923-B2 | Controlled cure for compositions comprising acetoacetylated resins | EASTMAN CHEMICAL COMPANY (US) | 2023-11-21 | — | — | US | claimed |
| EP-3894474-B1 | CURABLE COMPOSITIONS COMPRISING ACETOACETYLATED RESINS, ALDEHYDES AND CERTAIN AMINES | EASTMAN CHEM CO (US) | 2023-09-13 | — | — | EP | claimed |
| US-11530342-B2 | Curable compositions comprising acetoacetylated resins, aldehydes and certain amines | EASTMAN CHEMICAL COMPANY (US) | 2022-12-20 | — | — | US | claimed |
| US-11434400-B2 | Assembly components comprising curable compositions containing acetoacetylated resins | EASTMAN CHEMICAL COMPANY (US) | 2022-09-06 | — | — | US | claimed |
| US-11261359-B2 | Flexible substrates comprising curable compositions containing acetoacetylated resins | EASTMAN CHEMICAL COMPANY (US) | 2022-03-01 | — | — | US | claimed |
| EP-3894476-A1 | FLEXIBLE SUBSTRATES COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS | Eastman Chemical Company (US) | 2021-10-20 | — | — | EP | claimed |
| EP-3894475-A1 | ASSEMBLY COMPONENTS COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS | Eastman Chemical Company (US) | 2021-10-20 | — | — | EP | claimed |
| US-20180133664-A1 | Methods for Treating Filled Microporous Membranes | PPG INDUSTRIES OHIO, INC. | 2018-05-17 | — | — | US | claimed |
| CN-102666667-B | Functionalized highly branched melamine-polyamine polymers | BASF SE | 2015-03-04 | — | — | CN | claimed |
| EP-2513201-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | BASF SE (DE) | 2012-10-24 | — | — | EP | claimed |
| US-20120252987-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | BASF SE (DE) | 2012-10-04 | — | — | US | claimed |
| WO-2011073246-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | BASF SE (DE) | 2011-06-23 | — | — | WO | claimed |
| EP-1778713-B1 | METHOD FOR LABELLING AND PURIFYING NUCLEIC ACIDS OF INTEREST PRESENT IN A BIOLOGICAL SAMPLE TO BE TREATED IN A SINGLE REACTION VESSEL | BIOMERIEUX SA (FR) | 2008-12-31 | — | — | EP | claimed |
| JP-2007530024-A | — | — | 2007-11-01 | — | — | JP | claimed |
| EP-1727825-A1 | LABELLING REAGENTS, METHODS FOR THE SYNTHESIS OF SUCH REAGENTS AND METHODS FOR THE DETECTION OF BIOLOGICAL MOLECULES | BIOMERIEUX (FR) | 2006-12-06 | — | — | EP | claimed |
| WO-2005092910-A1 | LABELLING REAGENTS, METHODS FOR THE SYNTHESIS OF SUCH REAGENTS AND METHODS FOR THE DETECTION OF BIOLOGICAL MOLECULES | BIOMERIEUX (FR) | 2005-10-06 | — | — | WO | claimed |
| US-6545067-B1 | Polycarboxylate-based plasticizer and, as an air detrainer, butoxylated polyalkylenepolyamines or salts thereof mixed with a mineral building material comprising cement. | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120252987-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | PARN, INMT, SRM | CHRM2 1253/4885NFKB1 3129/4885CA12 545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.